Markets
BSE See NSE See 37,363.43
809.83 (2.22%)

DSIJ Mindshare

Granules India hits record high; zooms 92 per cent in 3 months

Ganesh V / Article rating: 4.5

Granules India Limited today announced that United States Food & Drug Administration (USFDA) has approved its abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC), which is a generic equivalent of Aleve PM Tablets, 220 mg/25 mg, of Bayer HealthCare LLC.

12345Last